MorphoSys shares soar over Novartis bid speculation; GKS moves forward with Phase II lupus, psoriasis studies;

 @FierceBiotech: Pfizer partner Protalix soars on sale speculation. Report | Follow @FierceBiotech

@JohnCFierce: So Elan has $3.25B to play with? Will they blow it? Analysis | Follow @JohnCFierce

@RyanMFierce: No surprise here. HISUN doesn't want exclusive license to Celsion's ThermoDox for the China market. Release | Follow @RyanMFierce

> Belgian Galapagos said GlaxoSmithKline ($GSK) plans to initiate Phase II studies with a therapy to treat systemic lupus erythematosus and chronic plaque psoriasis. Release

> Zheijang HISUN Pharmaceutical Company does not plan to pursue the exclusive option to license Celsion Corporation's ($CLSN) ThermoDox for the greater China market. Release

> In light of speculation that its shareholder Novartis ($NVS) might make a bid on the company, shares of MorphoSys, a German biotechnology company, rose to as much as 5.4% to €34.70 ($46.90)--the highest since March 2001. Story

Pharma News

@FiercePharma: GSK to hack jobs in Europe where austerity has taken toll. Report | Follow @FiercePharma

@EricPFierce: With sale of Tysabri rights to Biogen Idec, Elan is now flush with cash and looking for something to buy. News | Follow @EricPFierce

@AlisonBFierce: Merck and GlaxoSmithKline will work with the GAVI Alliance to provide low-cost HPV vaccines to developing countries. Article | Follow @AlisonBFierce

> Merck loses 'bellwether' Fosamax case. Article

> Is Hospira primed for a takeover? News

Medical Device News

 @FierceMedDev: Exosome draws $5M in financing for molecular Dx work. Item | Follow @FierceMedDev

 @MarkHFierce: House Majority Leader Eric Cantor has revived the device tax repeal push, as part of Republicans' new platform. Story | Follow @MarkHFierce

 @DamianFierce: Allergan is looking to sell off its Lap-Band business as revenues continue to plummet. News | Follow @DamianFierce

> HeartMate sales propel Thoratec's Q4 revenue jump. Article

> Zoll gains Japan's sign-off for intravascular temperature management device. Report

Drug Delivery News

> Cloaked nanoparticles look like blood cells, carry drugs. Story

> FDA to review BTG's varicose vein foam injection. News

> Rockwell shows iron delivery drug for dialysis improves treatment. Article

> Langer's Kala scores Cystic Fibrosis Foundation grant. Report

Biomarkers News

> Brain biomarker may help open door to personalized depression drugs. Report

> FDA will make use of GVK biomarker database. Item

> Biomarker could be key to MS Dx and targeted treatment. Article

> Molecules that could predict cancer growth detected. News

> Researcher names protein as plausible autism biomarker. Story

And Finally… NASA has released the first photos of the "comet of the century." Story